ArticleAdvances in therapy2024

Real-World Treatment Persistence Among Advanced Therapy-Naïve or -Experienced Patients with Ulcerative Colitis Initiated on Ustekinumab or Adalimumab.

Maryia Zhdanava et al.PubMed ↗Publisher ↗

No numbers read from the abstract.